Hydroxamic acid tetrapeptide derivatives
US5100874A · kind A · utility
15Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 1989 |
| Grant date | Mar 31, 1992 |
| Priority date | — |
| Expiry date | Aug 4, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
New peptide derivatives of which utility in the treatment of such diseases as rheumatoid arthritis, peridental diseases, corneal ulcer and epidermolysis bullosa is expected. These compounds are hydroxamic acid derivatives of tetrapeptides having a specific inhibitory activity against collagenase derived from vertebrates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.